The Food and Drug Administration (FDA) reported that Bystolic (nebivolol; Forest) tablets are currently in shortage.

In April 2015, The FDA had announced a shortage for Bystolic estimated to last 4–6 months. The update indicates that the 30- and 90-count bottles of Bystolic 20mg tablets are still on backorder and are unavailable. Forest has reported a manufacturing delay based upon commercial stability data. The backorder is estimated to last an additional 1–3 months but the Bystolic 10mg tablets are available to cover the demand for the 20mg tablets.

RELATED: FDA: Hypertension Tx Currently in Shortage

Bystolic is a cardioselective beta-blocker indicated for the treatment of hypertension in adults ≥18 years of age.

For more information call (800) 272-5525 or visit